Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/14/2003WO2003066069A1 Polymers for delivering peptides and small molecules in vivo
08/14/2003WO2003066068A1 Hpma-polyamine conjugates and uses therefore
08/14/2003WO2003066067A2 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003WO2003066066A1 Targeted drug delivery methods
08/14/2003WO2003066065A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
08/14/2003WO2003066064A2 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics
08/14/2003WO2003066063A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/14/2003WO2003066062A1 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
08/14/2003WO2003066061A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
08/14/2003WO2003066060A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
08/14/2003WO2003066059A1 Treatment of neuroblastoma
08/14/2003WO2003066058A1 Pharmaceutical composition for regeneration of cirrhotic liver
08/14/2003WO2003066056A1 Method of promoting neuronal growth
08/14/2003WO2003066055A1 Quinoline derivatives as npy antagonists
08/14/2003WO2003066054A1 Cationic polymers for use in therapeutic agent delivery
08/14/2003WO2003066053A1 Antibiotic polymers
08/14/2003WO2003066052A1 Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients
08/14/2003WO2003066051A1 Preventive and/or therapeutic agent for cardiac disorder
08/14/2003WO2003066050A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003WO2003066049A1 Combinations for the treatment of fungal infections
08/14/2003WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066046A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066045A1 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
08/14/2003WO2003066044A1 New medicinal compositions containing heterocyclical compounds in addition to anticholinergics
08/14/2003WO2003066043A1 Stimulation of cpt-1 as a means to reduce weight
08/14/2003WO2003066042A1 A non-arrhythmogenic metabolite of oxybutynin
08/14/2003WO2003066041A1 Carnitine in the treatment of geriatric depression
08/14/2003WO2003066040A1 Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist
08/14/2003WO2003066039A1 Combination therapy for treatment of schizophrenia
08/14/2003WO2003066038A1 Process to prepare semicarbazones’ and/or tiosemicarbazones’ formulations using cyclodextrins and their derivatives and products obtained by this process
08/14/2003WO2003066037A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
08/14/2003WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003WO2003066034A2 Use of compounds and compositions derived form olives for protecting cells against dna damage
08/14/2003WO2003066033A1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
08/14/2003WO2003066032A1 Formulations for inhalation
08/14/2003WO2003066031A1 Cyclodextrines for use as suspension stabilizers in pressure-liquefied propellants
08/14/2003WO2003066030A2 Pharmaceutical tablet
08/14/2003WO2003066029A2 Pharmaceutical dosage form for mucosal delivery
08/14/2003WO2003066028A1 Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
08/14/2003WO2003066027A1 Sterile lyophilized ifosfamide and associated methods
08/14/2003WO2003066026A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
08/14/2003WO2003066025A1 Clear micellized formulations of beta-carotene for treating leukoplakia
08/14/2003WO2003066024A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
08/14/2003WO2003066023A1 A stable pharmaceutical formulation comprising torsemide modification ii
08/14/2003WO2003066022A2 Stable pharmaceutical composition useful for treating gastrointestinal disorders
08/14/2003WO2003066021A2 Drug nanoparticles with lysozyme surface stabiliser
08/14/2003WO2003066020A1 Composition for easing human childbirth
08/14/2003WO2003066009A1 Topical ivermectin composition
08/14/2003WO2003066008A1 Method of enhancing hair growth
08/14/2003WO2003066005A2 Ansamycins having improved pharmacological and biological properties
08/14/2003WO2003066004A2 Therapeutic compounds
08/14/2003WO2003066001A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
08/14/2003WO2003065995A2 Method for treating diseases associated with abnormal kinase activity
08/14/2003WO2003065994A2 Schwann cell and phosphodiesterase inhibitors based therapy
08/14/2003WO2003065992A2 Treating benign prostate hyperplasia with sarms
08/14/2003WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003065988A2 A combination for treating cold and cough
08/14/2003WO2003065984A2 Methods and compositions for treating cardiovascular disease
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003065982A2 Engineering absorption of therapeutic compounds via colonic transporters
08/14/2003WO2003065975A2 Processes for preparing crystalline and amorphous mupirocin calcium
08/14/2003WO2003065971A2 Non-myeloablative tolerogenic treatment with tyrphostins
08/14/2003WO2003065970A2 Treatment of fibromyalgia and related fatigue syndromes using pindolol
08/14/2003WO2003065924A1 Control of a biological function
08/14/2003WO2003065881A2 Medical device with coating that promotes endothelial cell adherence and differentiation
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003065807A1 Formulations comprising triazoles and alkoxylated amines
08/14/2003WO2003065806A1 New immunoeffector compounds
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003WO2003055438A3 Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
08/14/2003WO2003049559A3 Method of producing a nicotine composition
08/14/2003WO2003048183A3 Method for obtaining oestrogen from mare urine
08/14/2003WO2003045437A8 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
08/14/2003WO2003045432A8 Treatment of neovascular ophthalmic disease
08/14/2003WO2003045331A3 Formulations for oral administration of cromolyn sodium
08/14/2003WO2003043647A3 A plant extract active as an immunostimulating agent
08/14/2003WO2003043586A3 Compositions for sustained action product delivery
08/14/2003WO2003038032A8 Means for inhibition of the synthesis of viral proteins
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003035237A3 Compounds for use as surfactants
08/14/2003WO2003035177A3 Optimal polymer mixtures for gastric retentive tablets
08/14/2003WO2003033499A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/14/2003WO2003032973A3 Composition comprising paracetamol and a bitterness masking component
08/14/2003WO2003031416A3 [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
08/14/2003WO2003030935A3 Adjuvants for nucleic acid vaccines
08/14/2003WO2003029433A3 Chimeric viral vectors for gene therapy
08/14/2003WO2003028648B1 Veterinaire florfenicol formulation that is syringeable under cold weather conditions
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003015699A3 Topical compositions and methods for treating pain
08/14/2003WO2003013655A3 Carbonic anhydrase inhibitors
08/14/2003WO2003012051A8 Inhibitor of dna methylation
08/14/2003WO2003004019A8 Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia
08/14/2003WO2003002713A3 Antibodies to opgl
08/14/2003WO2003002129B1 Use of sulodexide for the treatment of inflammatory bowel disease
08/14/2003WO2003000202A3 Particles for inhalation having rapid release properties
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
1 ... 5374 5375 5376 5377 5378 5379 5380 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 ... 7860